[{"indications": "Indications\u00a0potassium depletion (see notes above)", "name": "POTASSIUM CHLORIDE - ORAL POTASSIUM", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "9 Nutrition and blood", "9.2 Fluids and electrolytes", "9.2.1 Oral preparations for fluid and electrolyte imbalance", "9.2.1.1 Oral potassium", "POTASSIUM CHLORIDE"], "cautions": "Cautions\u00a0\n(From 9.2.1.1 Oral potassium: British National Formulary)\n9.2.1.1 Oral potassium; cardiac disease; elderly; with modified-release\r\npreparations, intestinal stricture, history of peptic\r\nulcer, hiatus hernia; interactions: Appendix 1 (potassium salts)", "side-effects": "Side-effects\u00a0nausea, vomiting, abdominal pain, diarrhoea, flatulence; with modified-release preparations, gastro-intestinal obstruction,\r\nulceration and bleeding also reported", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/4940.htm", "doses": ["See notes above", "Do not confuse Effervescent Potassium Tablets\r\nBPC 1968 (section 9.2.1.3) with effervescent potassium chloride tablets. Effervescent Potassium Tablets BPC 1968 do not contain\r\nchloride ions and their use should be restricted to hyperchloraemic\r\nstates (section 9.2.1.3). "]}, {"indications": "Indications\u00a0potassium depletion (see notes above)", "name": "POTASSIUM CHLORIDE Modified-release preparations", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "9 Nutrition and blood", "9.2 Fluids and electrolytes", "9.2.1 Oral preparations for fluid and electrolyte imbalance", "9.2.1.1 Oral potassium", "POTASSIUM CHLORIDE", "Modified-release preparations"], "cautions": "Cautions\u00a0\n(From 9.2.1.1 Oral potassium: British National Formulary)\n9.2.1.1 Oral potassium; cardiac disease; elderly; with modified-release\r\npreparations, intestinal stricture, history of peptic\r\nulcer, hiatus hernia; interactions: Appendix 1 (potassium salts)", "side-effects": "Side-effects\u00a0nausea, vomiting, abdominal pain, diarrhoea, flatulence; with modified-release preparations, gastro-intestinal obstruction,\r\nulceration and bleeding also reported", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/4942.htm", "doses": ["See notes above", "Do not confuse Effervescent Potassium Tablets\r\nBPC 1968 (section 9.2.1.3) with effervescent potassium chloride tablets. Effervescent Potassium Tablets BPC 1968 do not contain\r\nchloride ions and their use should be restricted to hyperchloraemic\r\nstates (section 9.2.1.3). ", "Name[Slow-K\u00ae (Alliance) ] Tablets, m/r, orange, s/c, potassium chloride 600\u00a0mg (8\u00a0mmol each of K+ and Cl-), net price 100 = \u00a31.90. \r\n    Label:\r\n    25, 27, counselling, swallow\r\nwhole with fluid during meals while sitting or standing"]}, {"indications": "Indications\u00a0electrolyte imbalance; see also oral potassium supplements, section\r\n9.2.1.1", "name": "POTASSIUM CHLORIDE - INTRAVENOUS POTASSIUM", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "9 Nutrition and blood", "9.2 Fluids and electrolytes", "9.2.2 Parenteral preparations for fluid and electrolyte imbalance", "9.2.2.1 Electrolytes and water", "Intravenous potassium", "POTASSIUM CHLORIDE"], "cautions": "Cautions\u00a0for intravenous infusion the concentration\r\nof solution should not usually exceed 3\u00a0g (40\u00a0mmol)/litre; specialist advice and ECG monitoring (\n(From Intravenous potassium: British National Formulary)\nPotassium chloride and sodium chloride intravenous infusion is the initial treatment for the correction of severe hypokalaemia and when sufficient potassium cannot be taken by mouth. Ready-mixed infusion solutions should be used when possible; alternatively, potassium chloride concentrate, as ampoules containing 1.5\u00a0g (K+ 20\u00a0mmol) in 10\u00a0mL, is thoroughly mixed with 500\u00a0mL of sodium chloride 0.9% intravenous infusion and given slowly over 2 to 3 hours, with specialist advice and ECG monitoring in difficult cases. Higher concentrations of potassium chloride may be given in very severe depletion, but require specialist advice.Repeated measurement of plasma-potassium concentration is necessary to determine whether further infusions are required and to avoid the development of hyperkalaemia, which is especially likely in renal impairment.Initial potassium replacement therapy should not involve glucose infusions, because glucose may cause a further decrease in the plasma-potassium concentration.); interactions: Appendix 1 (potassium salts)", "side-effects": "Side-effects\u00a0rapid infusion toxic to heart", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/4985.htm", "doses": ["By slow intravenous infusion, depending\r\non the deficit or the daily maintenance requirements, see also notes\r\nabove"]}, {"indications": "Indications\u00a0potassium depletion (see notes above)", "name": "POTASSIUM CHLORIDE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "9 Nutrition and blood", "9.2 Fluids and electrolytes", "9.2.1 Oral preparations for fluid and electrolyte imbalance", "9.2.1.1 Oral potassium", "POTASSIUM CHLORIDE"], "cautions": "Cautions\u00a0\n(From 9.2.1.1 Oral potassium: British National Formulary)\n9.2.1.1 Oral potassium; cardiac disease; elderly; with modified-release\r\npreparations, intestinal stricture, history of peptic\r\nulcer, hiatus hernia; interactions: Appendix 1 (potassium salts)", "side-effects": "Side-effects\u00a0nausea, vomiting, abdominal pain, diarrhoea, flatulence; with modified-release preparations, gastro-intestinal obstruction,\r\nulceration and bleeding also reported", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/4940.htm", "doses": ["See notes above", "Do not confuse Effervescent Potassium Tablets\r\nBPC 1968 (section 9.2.1.3) with effervescent potassium chloride tablets. Effervescent Potassium Tablets BPC 1968 do not contain\r\nchloride ions and their use should be restricted to hyperchloraemic\r\nstates (section 9.2.1.3). "]}]